Navigation Links
Aflac Reaches $40 Million Milestone in Donations to the Aflac Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta
Date:3/19/2008

Contributions Help Fund Ongoing Research, Facilities and Family Support

Services

ATLANTA, March 19 /PRNewswire/ -- In its ongoing support of the Aflac Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta, Aflac announced that it has reached more than $40 million in contributions to the Center, making it the largest corporate supporter of Children's Healthcare of Atlanta.

"With financial resources provided by Aflac, we have been able to recruit national leaders in the fields of pediatric cancer, sickle cell disease and experimental therapy and have also established a thriving program for cancer survivors," said William G. Woods, M.D., director for the Aflac Cancer Center. "These leaders are conducting important lab and clinical research and helping to bring innovative treatments to patients at the bedside - not just in Georgia, but nationwide."

Thousands of Aflac field force members across the country and the Aflac Foundation together have funded four endowed chairs at the Aflac Cancer Center, each of which provides critical funding in perpetuity for key positions at the Center. At Children's Healthcare of Atlanta, receiving a chair signifies a monetary endowment for a specific program directed by a physician or researcher. To date, Aflac has funded the following chairs:

-- Dr. William G. Woods - The Daniel P. Amos Children's Chair for the

Aflac Cancer Center and Blood Disorders Service

-- Dr. Donald Durden - The Aflac Field Force Cancer Experimental Therapy

Chair

-- Dr. Lillian R. Meacham - The Kathelen V. Amos Children's Chair for

Cancer Survivorship

-- Dr. Peter Lane - The Aflac Field Force Children's Chair for Sickle Cell

Disease

Over the years, Aflac's contributions have also been used to fund other critical needs, including new inpatient and outpatient facilities, a new state-of-the-art pediatric resea
'/>"/>

SOURCE Aflac
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Aflac Incorporated to Present at the Raymond James 29th Annual Institutional Investors Conference
2. Training Magazine Applauds Aflacs Employee Learning Programs
3. Aflac Incorporated Announces Fourth Quarter Results
4. Aflac Incorporated to Accelerate Share Repurchase in 2008; Authorizes Additional Share Repurchase and Increases Quarterly Cash Dividend 17.1%
5. Aflac to Sponsor Iron Girl
6. Aflac Incorporated to Present at the Goldman Sachs Financial Services CEO Conference 2007
7. Aflac Japan To Offer Cancer Insurance Product Through Japan Post
8. Aflac Honors Hispanic Entrepreneurs Making a Difference in Texas
9. Aflac Incorporated Announces Third Quarter Results, Declares Fourth Quarter Cash Dividend
10. Aflac Incorporated to Release Third Quarter Results On October 23, 2007
11. Aflac Announces Resignation of U.S. Marketing Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2008)...TSX: COM, VANCOUVER, July 23 /PRNewswire-FirstCal... today announced that it has entered into an,agree...ment fund managed by,CR Intrinsic Investors, LLC, ...rchase Series A convertible preferred shares for g...nancing will be used for general corporate,purpose...
(Date:7/23/2008)...ce the idea of using DNA to create faster, smaller...scientists have been scrambling to develop success... new research from a professor at Rensselaer Polyt... out artificial computations, all we have to do is... Cognitive Science Mark Changizi has begun to deve...
(Date:7/23/2008)..., July 23 /PRNewswire-USNewswire/ -- The Children,...e a generous $15 million,gift that will enable the...own, Pennsylvania. This gift, made possible by Ath...is one of the largest in the history of,Children,s...milies in the,nearby communities convenient access...
(Date:7/23/2008)...ly 23 /PRNewswire/ -- Times may be tough, but,Holl...there,s nothing like,a dazzling new smile to boost...DDS helps his celebrity clients beam in on success...ngs with it the self-confidence they,need for star...ting a new,high-wattage smile designed by Dr. Kosd...
Breaking Medicine News(10 mins):Health News:Cardiome Announces Preferred Share Financing 2Health News:Cardiome Announces Preferred Share Financing 3Health News:Study suggests human visual system could make powerful computer 2Health News:Study suggests human visual system could make powerful computer 3Health News:$15 Million Donation From The Karabots Foundation Enables The Children's Hospital of Philadelphia to Open a New Pediatric Care Facility in Norristown, Pennsylvania 2Health News:$15 Million Donation From The Karabots Foundation Enables The Children's Hospital of Philadelphia to Open a New Pediatric Care Facility in Norristown, Pennsylvania 3Health News:Rock The Cradle's Bad Boy Landon Brown Owes His Irresistible New Smile to Dr. Michael Kosdon 2
...ng patients on urinary catheters longer than neces...fections and blood infections, said a new study pu... and Patient Safety. The study says that a simple ...f for the doctors might solve this problem. Resear...
...be caused by Streptococcus suis and the first case...f China. The infected persons were mostly farmers ...who handled the contaminated pork products. Accord... are thought to have come from up to 300 different...
...sity of Michigan Cardiovascular Center had present...bon monoxide that can cure inflammations in patien...r heart attacks. In a recent study the scientists ...of carbon monoxide for several weeks after transpl...
...ogressive, neurodegenerative and ultimately fatal ...vanced stage, Alzheimer's disease sufferers lose t...help in every aspect of their everyday living. Bas...rchers say that a mixture of peptides derived from...
Other Medicine News:Health News:Patients Are Given Catheter Longer Than Necessary 2Health News:Research Shows Carbon Monoxide Prevents Inflammations 2
(Date:7/23/2008)... ASPS Study Finds Some Areas of the Body Have G...IGHTS, Ill., July 23 /PRNewswire-USNewswire/ -- Fa...hrough liposuction was found to be,an excellent so...ations,than other areas of the body, reports a Bra...ructive Surgery(R), the official medical journal o...
(Date:7/23/2008)... SEATTLE, July 23 /- Den... that it expects the Independent Data,Monitoring C...rim analysis,of overall survival relating to the C...e AdenoCarcinoma Treatment, also known as D9902B) ...ENGE is the Company,s investigational,active cellu...
(Date:7/22/2008)... BRISBANE, Australia, July 22 /PRNewswire-First...d late yesterday, the Board of Progen,Pharmaceutic...ed that it,had discontinued the PI-88 phase 3 stud...direction to develop its existing portfolio of com...re additional compounds and,opportunities through ...
(Date:7/22/2008)... MINNEAPOLIS, July 22 /- Nonin Med...ing solutions for more than 20 years, has entered,...echnology to measure,regional oxygen saturation. T... is the continuous monitoring of the regional bloo... Early testing data and outcomes from an ongoing c...
Breaking Medicine Technology:Want a Reason to Love Your Lower Belly Fat? It's Rich in Stem Cells 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 3Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market 2MEDdevice Acquisition Co LLC and Epsilon Securities LLC Identify Sources of Funding 21481 1MEDdevice Acquisition Co LLC and Epsilon Securities LLC Identify Sources of Funding 21481 2The Glazier Group Removes Tomatoes from Menus Nationwide 21478 1The Glazier Group Removes Tomatoes from Menus Nationwide 21478 2Oncolytics Biotech Inc Announces Start of Enrolment in Phase 1 2 Ovarian Cancer Clinical Trial with REOLYSIN 28R 29 5914 1Oncolytics Biotech Inc Announces Start of Enrolment in Phase 1 2 Ovarian Cancer Clinical Trial with REOLYSIN 28R 29 5914 2Oncolytics Biotech Inc Announces Start of Enrolment in Phase 1 2 Ovarian Cancer Clinical Trial with REOLYSIN 28R 29 5914 3Miltenyi Biotec GmbH Acquires Medic Tools AG 5911 1Miltenyi Biotec GmbH Acquires Medic Tools AG 5911 2
...as been widely used as the gold standard for prost...reversals in recent diagnostic science, a recent s... findings by other researchers have now put the ut...ed, The PSA era is over in the United States, said...author of the study published in the October 2004 ...
... between analog and digital television sets, so, t...oose between analog and digital mammography units,... centers around the country., ,As of late 2003...cleared four digital mammography units for clinica...graphy systems, approved in January 2000 and manuf...
Other Medicine Technology:PSA TestingHow Much is Too Much? 2PSA TestingHow Much is Too Much? 3Digital vs. Analog Mammography 2Digital vs. Analog Mammography 3Digital vs. Analog Mammography 4
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
Medicine Products: